Barclays Raises its Price Target on CytomX Therapeutics, Inc. (CTMX) to $10 and Maintains an Overweight Rating

On February 4, 2026, Barclays raised its terms people connected CytomX Therapeutics, Inc. (NASDAQ:CTMX) to $10 from $8 and maintained an Overweight standing arsenic portion of a fourth-quarter net preview for the biotechnology group.

Earlier, connected January 20, 2026, Piper Sandler lifted its terms people to $10 from $6.50 and kept an Overweight standing pursuing archetypal Phase I information connected varsetatug maseatecan. The steadfast noted that doses of 7.2–10 mg/kg delivered a 28% wide effect rate, a 94% illness power rate, and a preliminary median progression-free endurance of 5.8 months successful third-line and aboriginal metastatic colorectal cancer. CytomX is expected to supply an update this 4th connected astir 100 mCRC patients crossed 7.2 mg/kg, 8.6 mg/kg, and 10 mg/kg q3W enlargement cohorts, with Piper anticipating dose-dependent ORR and PFS benefits. Also connected January 20, 2026, Guggenheim expert Michael Schmidt initiated sum with a Buy standing and a $10 terms target, citing what helium described arsenic “extraordinary” antitumor enactment from Varseta-M successful a heavy pre-treated population. The firm’s $10 people reflects 30% likelihood of occurrence successful third-line and aboriginal colorectal cancer.

CytomX Therapeutics, Inc. (NASDAQ:CTMX) develops conditionally activated biologics targeting the tumor microenvironment, including antibody-drug conjugates, T-cell engagers, immune modulators, and its PROBODY level for oncology and preclinical applications.

While we admit the imaginable of CTMX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Most Profitable Undervalued Stocks to Buy and 11 Best Mining Stocks to Buy According to Wall Street

Disclosure: None.